Dr Chiung-Kuei Huang
Dr Huang is a research associate of Liver Research Center of Rhode Island Hospital and of Warren Alpert Medical School at Brown University. His researches mainly focus on liver diseases including the liver cancers and alcoholic liver diseases.
Dr. Huang obtained his PhD in 2011 from the University of Rochester Medical Center. Since 2015, Dr. Huang has served as a Research Associate for the Liver Research Center of Rhode Island Hospital and Warren Alpert Medical School of Brown University. Dr. Huang has served as associated editor for Nephrology - Open Journal.
Dr. Huang has explored the role of aspartate beta-hydroxylase (ASPH) in malignant progression of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), developed pharmacological compounds to target ASPH in these cancers, and obtained convincing therapeutic outcomes of treating HCC and CCA by using the pharmacological compounds in preclinical studies.
Dr. Huang has published several peer-reviewed papers in various pharmacology and medical journals including Hepatology, Clinical Cancer Research, Journal of Biological Chemistry, EMBO Molecular Medicine, and Clinical Cancer Research. He has also published several book chapters and conference abstracts.